FDA patient panel offers ideas to improve trial participation

Panelists on FDA's Patient Engagement Advisory Committee (PEAC) concluded the group's inaugural meeting with recommendations for improving recruitment, retention and results communication in clinical trials of medical devices. The panel did not vote on any questions.

Committee members recommended that clinical trial stakeholders develop a framework for providing patient input at each step of the product development life cycle. ...